Navigation Links
EpiCept Corporation to Present New NP-1 Data at American Pain,Society Meeting

itionally, the study met the following secondary endpoints: a responder analysis of improvement in pain intensity (p<0.025), a responder analysis of improvement in pain relief (p<0.01), improvement in patient sleep scores (p=0.028) and overall patient global satisfaction (p=0.04). This study also found that significant neuropathic pain relief was achieved at a small fraction of the plasma levels observed after systemic dosing. The cream was found to be safe and well tolerated across all age groups studied.

"These findings add to a growing body of clinical data which demonstrate the potential for NP-1 to provide effective, additive, long-term relief to the 15 million Americans who suffer from the pain of peripheral neuropathies. The outcome from the pharmacokinetic trial in particular supports the safety of NP-1 topical cream and even more importantly its ability to be added to orally administered therapies," remarked Jack Talley, President and CEO of EpiCept. "We believe NP-1 has the largest market potential of any of our pain product candidates and we are focused on advancing it through its current Phase IIb trials. These trials are progressing as expected and we remain on track to be able to share preliminary results from the first trial by the fourth quarter of 2007.

"Current systemically-delivered analgesics have well documented limitations and significant potential side effects. The local mechanism of action of NP-1 demonstrated in these studies could reduce these side effects by blocking pain directly at its source," remarked Stephane Allard, MD, Chief Medical Officer.

EpiCept NP-1 is currently undergoing two Phase IIb trials, enrolling a total of 700 patients. The first trial is a 200 patient, placebo-controlled study of NP-1 in patients with diabetic peripheral neuropathy (DPN). More patients suffer from DPN than any other type of neuropathic pain. Only two medications are currently approved for this use. The trial is intended to confirm
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
2. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
4. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
5. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
6. The Past, Present and Future of HLA Typing
7. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
Post Your Comments:
(Date:3/4/2015)... Alimera Sciences, Inc. (NASDAQ: ... in the research, development and commercialization of prescription ... fourth quarter and year ended December 31, 2014. ... year for Alimera Sciences, most notably having received ... the treatment of diabetic macular edema," said Dan ...
(Date:3/4/2015)... March 4, 2015 Acsis Inc., the market ... solutions, announced it will be hosting a free webinar ... event, "How to Boost Manufacturing Efficiency and Optimize Supply ... at 2:00 PM EDT.  Presenters ... John Gordon , Chief Information Officer for Roosevelt ...
(Date:3/4/2015)... , March 4, 2015   Mayo Clinic ... to develop the next generation of wearable biosensors designed ... hoping that this technology will be game-changer. These patch ... says James Levine, M.D., Ph.D. , a Mayo ... accurate, inexpensive, and can be integrated into the care ...
Breaking Medicine Technology:Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 2Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 3Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 4Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 5Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 6Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 7Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 8Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 9Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 10Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 11Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 12Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 13Alimera Sciences Reports Fourth Quarter and Full Year 2014 Financial Results 14Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
... Feb. 8, 2012   Resource Anesthesia , an anesthesia ... several new locations to its management portfolio. ... announced today that the company has added the following ... Specialty Hospital of Washington -- Hadley, 4601 Martin Luther ...
... MLAB ) today reported a 21 percent increase in revenue and ... quarter ended December 31, 2011. Highlights: ... ,000 Quarterly revenues increased 21% year over year to ... in the fiscal third quarter Quarterly non-GAAP diluted earnings ...
Cached Medicine Technology:Resource Anesthesia Adds Locations Under Management, Announces Addition of HealthStream LearningCenter® 2Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 2Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 3Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 4Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 5
(Date:3/4/2015)... When people talk about venues being the place ... numerous genres, the Houston Rodeo will be a ... the annual livestock show and rodeo, one popular band will ... being held at the event. The 2015 show will feature ... try and get the festival its largest attendance ever. , ...
(Date:3/4/2015)... The federal litigation established for Lipitor ... caused patients to develop Type 2 diabetes continues to ... South Carolina. According to court documents, the proceeding’s next ... at 10:00 a.m. In advance of the Conference, the ... report to the Court by March 19, 2015. (In ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 FDA’s New ... , **FDAnews Webinar**, March 24, 2015 — 1:30 p.m. ... investigators generally know within four hours of an inspection ... manufacturer is on their “good” list, they’ll merely ask ... a manufacturer is on the “bad” list, the manufacturer ...
(Date:3/4/2015)... VIENNA, Austria (PRWEB) March 04, 2015 ... to reduce subjectivity in density assessment and help ... focus of numerous abstracts accepted for presentation at ... 3-8, 2015. Ten abstracts - eight posters ... of Volpara Solutions’ automated breast density and quantitative ...
(Date:3/4/2015)... 04, 2015 With the growing influence of ... of our teens and young adults, combined with the increasingly ... confusing to try to keep up with what kids are ... trend is replaced on a daily basis. , The same ... the slang that is used to discreetly talk about them, ...
Breaking Medicine News(10 mins):Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2
... disability in the United States, and public school systems ... 166 children is diagnosed with autism, making it more ... ,The Autism Support Services: Education, Research, and Training ... preschool program that uses research-based techniques to address the ...
... the liver are excellent targets for gene therapy using adenoviral ... the differences between cancerous and normal liver cells. The findings ... to the liver, such as metastatic cancers of the colon ... Reid, M.D., Ph.D., of the Moores Cancer Center at University ...
... up the social ladder than bottle-fed children, reveals a large, ... of Disease in Childhood. ,Over 3000 children from ... monitored from birth, as part of the Boyd Orr Study ... ,The study results are based on 1414 people in their ...
... never meet’- health care and mobile technology, it is ... powerful groups - the GSM Association's Development Fund, the ... Accenture Development Partnership, Motorola Inc., MTN South Africa, and ... improve the AIDS/HIV scenario in Africa. ,'The ...
... with lung cancer has won $ 1 million in a lottery. ... an inoperable lung cancer. ,Doctors have given him a ... juncture, he has won this lottery. But the irony that is ... in annual installments over twenty years. ,Schenk is a ...
... for more funds to flow, for those connected with the ... , He was speaking at a meeting where he released ... victims. , The 83-page script was released more ... recovery workers exposed to the dust — a combination of ...
Cached Medicine News:Health News:Autism Expert Creates Innovative Intervention Program 2Health News:Autism Expert Creates Innovative Intervention Program 3Health News:Liver an Excellent Target For Cancer Gene Therapy 2Health News:Liver an Excellent Target For Cancer Gene Therapy 3Health News:Mobile Technology to Meet Healthcare Needs 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: